| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Cell Sheet Migration Inhibitor, Locostatin | 133812-16-5 | sc-203875 | 10 mg | $222.00 | 3 | |
Locostatin functions as a potent inhibitor of cell sheet migration, primarily through its role as a regulator of protein interactions. It selectively disrupts the binding of specific kinases, thereby modulating signaling pathways that govern cellular motility. The compound's unique structural features facilitate its engagement with target proteins, leading to altered phosphorylation states. This modulation can significantly impact cellular dynamics and spatial organization within tissues. | ||||||
Necrostatin-1 | 4311-88-0 | sc-200142 sc-200142A | 20 mg 100 mg | $92.00 $336.00 | 97 | |
Necrostatin-1 inhibits RIPK1, preventing necroptosis by disrupting RIPK1-RIPK3 interactions. It is a potent RIPK1 kinase inhibitor. | ||||||
AP 24534 | 943319-70-8 | sc-362710 sc-362710A | 10 mg 50 mg | $172.00 $964.00 | 2 | |
Ponatinib is a multi-kinase inhibitor, including RIPK1, which suppresses RIPK1-mediated signaling, | ||||||
Dabrafenib | 1195765-45-7 | sc-364477 sc-364477A sc-364477B sc-364477C sc-364477D | 5 mg 25 mg 50 mg 100 mg 10 g | $138.00 $255.00 $273.00 $403.00 $12240.00 | 6 | |
Dabrafenib, primarily a BRAF inhibitor, also inhibits RIPK1, thereby suppressing RIPK1-mediated necroptosis and inflammation in various pathological conditions. | ||||||
Emricasan | 254750-02-2 | sc-507387 | 5 mg | $90.00 | ||
Emricasan, a caspase inhibitor, indirectly inhibits RIPK1 by preventing its cleavage and activation, leading to reduced necroptosis in liver diseases and other conditions. | ||||||